Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M383Revenue $M0.2Net Margin (%)--Altman Z-Score15.2
Enterprise Value $M309EPS $-0.6Operating Margin %--Piotroski F-Score2
P/E(ttm)--Beneish M-Score-1.7Pre-tax Margin (%)--Higher ROA y-yN
Price/Book3.610-y EBITDA Growth Rate %--Quick Ratio20.6Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %-9.8Current Ratio20.6Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-49.8Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-55.4Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M102ROIC % (ttm)-231.8Gross Margin Increase y-yN

Gurus Latest Trades with ONTY

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ONTYFirst Eagle Investment 2015-03-31 Buy 0.01%$1.5 - $1.95
($1.63)
$ 3.70127%New holding1,300,000
ONTYFirst Eagle Investment 2014-09-30 Sold Out -0.02%$2 - $3.29
($2.54)
$ 3.7046%Sold Out0
ONTYGeorge Soros 2014-06-30 Sold Out $2.35 - $3.5
($2.94)
$ 3.7026%Sold Out0
ONTYGeorge Soros 2014-03-31 Buy $1.71 - $3.89
($2.7)
$ 3.7037%New holding89,600
ONTYFirst Eagle Investment 2013-09-30 Add0.01%$1.59 - $2.18
($1.75)
$ 3.70111%Add 75.63%2,275,287
ONTYFirst Eagle Investment 2013-06-30 Add0.01%$1.57 - $2.63
($2.14)
$ 3.7073%Add 547.75%1,295,499
ONTYFirst Eagle Investment 2013-03-31 Buy $1.86 - $2.35
($2.09)
$ 3.7077%New holding200,000
ONTYFirst Eagle Investment 2012-03-31 Sold Out -0.0033%$4.16 - $8.96
($6.31)
$ 3.70-41%Sold Out0
ONTYFirst Eagle Investment 2011-12-31 Add$5.84 - $8.25
($6.85)
$ 3.70-46%Add 33.33%100,000
ONTYFirst Eagle Investment 2011-09-30 Reduce-0.01%$5.95 - $10.2
($7.49)
$ 3.70-51%Reduce 66.67%75,000
ONTYFirst Eagle Investment 2011-06-30 Buy 0.01%$3.8 - $9.43
($5.79)
$ 3.70-36%New holding225,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ONTY is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


ONTY: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
HAUSMAN DIANAChief Medical Officer 2015-06-01Buy5,747$4.65-20.43view
SPIEGELMAN DANIEL KDirector 2015-03-26Buy20,000$1.61129.81view
SPIEGELMAN DANIEL KDirector 2015-03-26Buy20,000$1.61129.81view
BVF PARTNERS L P/IL10% Owner 2014-12-17Buy378,444$1.82103.3view
BVF PARTNERS L P/IL10% Owner 2014-12-12Sell0$0103.3view
Venkatesan JayEVP and General Manager 2014-09-23Buy250,000$285view
BVF PARTNERS L P/IL10% Owner 2013-11-01Buy129,000$1.78107.87view
BVF PARTNERS L P/IL10% Owner 2013-08-08Buy258,361$1.65124.24view
BVF PARTNERS L P/IL10% Owner 2013-08-01Buy338,087$1.74112.64view
SPIEGELMAN DANIEL KDirector 2013-07-10Sell16,183$1.9193.72view

Quarterly/Annual Reports about ONTY:

News about ONTY:

Articles On GuruFocus.com
Value Betting with Special Situations: Lessons from the World of Gambling Mar 05 2013 
pro-longs life Jul 30 2011 
Cubist Pharmaceutical - Acutely Aware May 09 2010 
Cubist Pharmaceutical - Acutely Aware May 09 2010 
cooldecency99 note on ONTY May 01 2010 
creiter note on ONTY Jan 03 2010 

More From Other Websites
ONCOTHYREON INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Jun 11 2015
How 6 ASCO Biotech Winners Are Focusing on the Future of Cancer Jun 07 2015
Top-Performing Biotech and Drug Stocks During ASCO '15 Jun 04 2015
Are Any Of These On Your 'Penny Stocks To Watch' List Jun 01 2015
Oncothyreon (ONTY) Stock Spikes Following Presentation on Breast Cancer Treatment Candidate Jun 01 2015
6 Key Cancer Winners From ASCO Presentations Jun 01 2015
ASCO targets immunotherapy and drug costs Jun 01 2015
Oncothyreon shares rise on study results Jun 01 2015
Oncothyreon shares rise on study results Jun 01 2015
Oncothyreon Breast Cancer Drug Exits ASCO '15 With Good Buzz Jun 01 2015
Oncothyreon Announces Presentation of Positive ONT-380 Data in HER2-Positive Breast Cancer at ASCO... May 30 2015
Oncothyreon Announces Presentation of Positive ONT-380 Data in HER2-Positive Breast Cancer at ASCO... May 30 2015
What Biotechnology Stocks Will Be Next To Enjoy The Bull Market? May 29 2015
Two Small Companies Seeking to Achieve Breakthroughs with Anti-Cancer Drugs at ASCO 2015 May 28 2015
Oncothyreon (ONTY) Looks Good: Stock Moves 16% Higher - Tale of the Tape May 27 2015
Oncothyreon to Present at Jefferies 2015 Healthcare Conference May 26 2015
Biotech Stock Mailbag: ASCO Preview, CAR-T stocks, MannKind, Hate Mail! May 22 2015
ONCOTHYREON INC. Financials May 19 2015
Oncothyreon (ONTY) Looks Good: Stock Up 6.6% in Session - Tale of the Tape May 19 2015
Why Oncothyreon (ONTY) is Poised to Beat Earnings Estimates - Tale of the Tape May 19 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK